Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ACVA | PAG |
|---|---|---|
| Price | $10.50 | $200.59 |
| Change today | ▲ 0.48% | ▼ 1.69% |
| Market cap | $1.78B | $13.17B |
| Return, 3 months | +44.0% | +9.2% |
| Return, year to date | +30.9% | +29.8% |
| Return, 1 year | +8.4% | +21.1% |
| P/E (TTM) | -28.4 | 14.6 |
| P/B | 4.6 | 2.3 |
| P/E percentile vs own 5y | – | 96th |
| Dividend yield | – | 2.75% |
| Revenue growth (YoY, latest qtr) | – | +6.0% |
| Net profit growth (YoY) | – | -2.4% |
| Gross margin | – | 16.1% |
| Operating margin | – | 3.8% |
| Net margin | – | 2.8% |
| Return on equity | – | 15.9% |
| Analyst target vs. price | -18.1% | +7.2% |
| Analyst buy share | 20% | 50% |
| RSI (14) | 78 | 32 |
| 30-day volatility | 109.2% | 14.1% |
| Max drawdown, 1 year | -59.3% | -20.0% |
| Trend read | Strong uptrend | Leaning bearish |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
